Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence

被引：8

作者：

Toesca, Antonio ^{[1
]}

Botteri, Edoardo ^{[2
,3
]}

Lazzeroni, Matteo ^{[4
]}

Vila, Jose ^{[1
]}

Manika, Aikaterini ^{[1
]}

Ballardini, Bettina ^{[1
]}

Bettarini, Francesca ^{[1
]}

Guerrieri-Gonzaga, Aliana ^{[4
]}

Bonanni, Bernardo ^{[4
]}

Rotmensz, Nicole ^{[2
]}

Viale, Giuseppe ^{[5
]}

Veronesi, Paolo ^{[1
]}

Luini, Alberto ^{[1
]}

Veronesi, Umberto ^{[6
]}

Gentilini, Oreste ^{[1
]}

机构：

[1] European Inst Oncol, Div Breast Surg, I-20141 Milan, Italy

[2] European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy

[3] Univ Milan, Dept Occupat Hlth, Milan, Italy

[4] European Inst Oncol, Div Canc Prevent & Genet, I-20141 Milan, Italy

[5] European Inst Oncol, Div Pathol, I-20141 Milan, Italy

[6] European Inst Oncol, Sci Directorate, I-20141 Milan, Italy

来源：

BREAST | 2014年 / 23卷 / 06期

关键词：

Ductal carcinoma in situ; Breast cancer; DCIS; DIN; Radiation therapy; CARCINOMA-IN-SITU; LOW-DOSE TAMOXIFEN; LOCAL RECURRENCE; CANCER; THERAPY; WOMEN; TRIAL; PREDICTORS; EXPRESSION;

D O I：

10.1016/j.breast.2014.08.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Rational: We retrospectively analyzed 232 patients affected by well differentiated ductal intraepithelial neoplasia (DIN1c or DCIS G1) treated with conservative surgery without adjuvant radiotherapy. Results: 25 invasive and 18 non-invasive local recurrences were observed ( median follow-up 80 months; 5-year cumulative incidence: 12.2%). Seven of the 15 young patients (<40 y) developed local recurrence (2 in situ, 5 invasive). Age <50 (HR 1.89, 95% C.I. 1.01-3.45), multifocality (HR 3.21, 95% C.I. 1.46-7.06), Ki-67 > 7% (HR 2.33, 95% C.I. 1.20-4.55) and surgical margins <10 mm (HR 2.00, 95% C.I. 1.06-3.76) were significantly associated with an increased risk of local recurrence. Conclusions: Young age, multifocality and small margins appeared as clear risk factors of local recurrence in DIN1c (DCIS G1) population. The presence of multiple poor prognostic features warrant a thorough discussion regarding local treatment. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：829 / 835

页数：7

共 50 条

[41] Regional Lymphatic Recurrence After Salvage Surgery for Ipsilateral Breast Tumor Recurrence of Breast Cancer Without Local Treatment for Regional Lymphatic Basin
Ishitobi, Makoto
Matsushita, Ako
Nakayama, Takahiro
Motomura, Kazuyoshi
Koyama, Hiroki
Tamaki, Yasuhiro
JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (03) : 265 - 269
[42] Increased Risk for Ipsilateral Breast Tumor Recurrence in Invasive Lobular Carcinoma after Accelerated Partial Breast Irradiation Brachytherapy
Mills, Matthew N.
Russo, Nicholas W.
Fahey, Matthew
Nanda, Ronica H.
Raiker, Sunny
Jastrzebski, Jessica
Stout, Lisa L.
Wilson, Jason P.
Altoos, Taghrid A.
Allen, Kathleen G.
Blumencranz, Peter W.
Diaz, Roberto
ONCOLOGIST, 2021, 26 (11) : E1931 - E1938
[43] Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma
Kim, Ji Won
Roh, Jong-Lyel
Gong, Gyungyup
Cho, Kyung-Ja
Choi, Seung-Ho
Nam, Soon Yuhl
Kim, Sang Yoon
THYROID, 2016, 26 (02) : 262 - 270
[44] Risk Factors Associated to Residual Tumor in Re-excision for Positive Margins in Breast Conservative Surgery
Sarre-Lazcano, Catherine
Clemente-Gutierrez, Uriel
Pastor-Sifuentes, Francisco U.
Medina-Franco, Heriberto
AMERICAN SURGEON, 2022, 88 (09) : 2368 - 2373
[45] Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
van Seijen, Maartje
Lips, Esther H.
Fu, Liping
Giardiello, Daniele
van Duijnhoven, Frederieke
de Munck, Linda
Elshof, Lotte E.
Thompson, Alastair
Sawyer, Elinor
Ryser, Marc D.
Hwang, E. Shelley
Schmidt, Marjanka K.
Elkhuizen, Paula H. M.
Wesseling, Jelle
Schaapveld, Michael
BRITISH JOURNAL OF CANCER, 2021, 125 (10) : 1443 - 1449
[46] Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR
Ishitobi, Makoto
Okumura, Yasuhiro
Nishimura, Reiki
Nakatsukasa, Katsuhiko
Tanabe, Masahiko
Yoshida, Atsushi
Masuda, Norikazu
Shien, Tadahiko
Tanaka, Satoru
Komoike, Yoshifumi
Arima, Nobuyuki
Taguchi, Tetsuya
Inaji, Hideo
BREAST CANCER, 2014, 21 (06) : 754 - 760
[47] Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence
Poodt, Ingrid G. M.
Walstra, Coco J. E. F.
Vugts, Guusje
Maaskant-Braat, Adriana J. G.
Voogd, Adri C.
Schipper, Robert-Jan
Nieuwenhuijzen, Grard A. P.
Roumen, R. M. H.
Luiten, E. J. T.
Rutgers, E. J. T.
Vrancken-Peeters, M. T. F. D.
Bessems, M.
Klaase, M.
Muller, S.
Francken, A. B.
Van Dalen, T.
Jansen, L.
Koopal, S. A.
Vissers, Y. L. J.
Smidt, M. L.
Merkus, J. W. S.
Contant, C. M. E.
Veldman, P. H.
Linthorst-Niers, E. M. H.
van der Sijp, J. R.
Guicherit, O. R.
Koppert, L. B.
Bosch, A. M.
Strobbe, L. J. A.
Schlooz-Vries, M. S.
Arntz, I. E.
van Essen, J. A.
de Waard, J. W. D.
Vrouenraets, B. C.
van Ooijen, B.
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (08) : 2417 - 2427
[48] Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?
Ling, Diane C.
Sutera, Philip A.
Iarrobino, Nick A.
Diego, Emilia J.
Soran, Atilla
Johnson, Ronald R.
Bhargava, Rohit
Champ, Colin E.
Beriwal, Sushil
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (04): : 869 - 876
[49] Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery - Preliminary results
Komoike, Y
Motomura, K
Inaji, H
Kasugai, T
Koyama, H
ONCOLOGY, 2003, 64 (01) : 1 - 6
[50] Outcomes of ipsilateral breast tumor recurrence after breast conserving surgery: Repeat lumpectomy as an alternative to salvage mastectomy
ElSherif, Ayat
Shah, Chirag
Downs-Kelly, Erinn
Alhareb, Alia
Valente, Stephanie A.
Tu, Chao
Al-Hilli, Zahraa
SURGERY, 2022, 171 (03) : 673 - 681

← 1 2 3 4 5 →